262 related articles for article (PubMed ID: 34965028)
1. A prospective study examining the expression of STAT 1, 3, 6 in prurigo nodularis lesions with its immunopathogenic and therapeutic implications.
Agrawal D; Sardana K; Mathachan SR; Bhardwaj M; Ahuja A; Jain S
J Cosmet Dermatol; 2022 Sep; 21(9):4009-4015. PubMed ID: 34965028
[TBL] [Abstract][Full Text] [Related]
2. A Prospective Study Examining the Effect of Selected Topical and Systemic Drugs on Pruritus Grading System Score and STAT 6 Expression in Patients of Prurigo Nodularis.
Agrawal D; Sardana K; Mathachan SR; Bhardwaj M; Ahuja A; Jain S
Indian J Dermatol; 2021; 66(6):638-644. PubMed ID: 35283533
[TBL] [Abstract][Full Text] [Related]
3. Nuclear localization of activated STAT6 and STAT3 in epidermis of prurigo nodularis.
Fukushi S; Yamasaki K; Aiba S
Br J Dermatol; 2011 Nov; 165(5):990-6. PubMed ID: 21711341
[TBL] [Abstract][Full Text] [Related]
4. Prurigo nodularis: new insights into pathogenesis and novel therapeutics.
Liao V; Cornman HL; Ma E; Kwatra SG
Br J Dermatol; 2024 May; 190(6):798-810. PubMed ID: 38345154
[TBL] [Abstract][Full Text] [Related]
5. Prurigo Nodularis: Pathogenesis and the Horizon of Potential Therapeutics.
Yook HJ; Lee JH
Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791201
[TBL] [Abstract][Full Text] [Related]
6. Abnormal keratin expression pattern in prurigo nodularis epidermis.
Yang LL; Jiang B; Chen SH; Liu HY; Chen TT; Huang LH; Yang M; Ding J; He JJ; Li JJ; Yu B
Skin Health Dis; 2022 Mar; 2(1):e75. PubMed ID: 35665210
[TBL] [Abstract][Full Text] [Related]
7. Aberrant Expression of Histamine-independent Pruritogenic Mediators in Keratinocytes may be Involved in the Pathogenesis of Prurigo Nodularis.
Zhong W; Wu X; Zhang W; Zhang J; Chen X; Chen S; Huang H; Yang Y; Yu B; Dou X
Acta Derm Venereol; 2019 May; 99(6):579-586. PubMed ID: 30809683
[TBL] [Abstract][Full Text] [Related]
8. Skin Microbiome in Prurigo Nodularis.
Tutka K; Żychowska M; Żaczek A; Maternia-Dudzik K; Pawełczyk J; Strapagiel D; Lach J; Reich A
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108838
[TBL] [Abstract][Full Text] [Related]
9. A critical evaluation of nemolizumab for prurigo nodularis.
Brooks SG; Yosipovitch G
Expert Rev Clin Immunol; 2024 Jun; 20(6):577-587. PubMed ID: 38217530
[TBL] [Abstract][Full Text] [Related]
10. [Pathogenesis of prurigo nodularis].
Raap U; Günther C
Hautarzt; 2014 Aug; 65(8):691-6. PubMed ID: 25113327
[TBL] [Abstract][Full Text] [Related]
11. A case-control study addressing the population of epidermal and dermal inflammatory infiltrate including neural milieu in primary prurigo nodularis using S-100 and toluidine blue stain and its therapeutic implications.
Agrawal D; Sardana K; Mathachan SR; Bhardwaj M; Ahuja A; Jain S; Panesar S
Int J Dermatol; 2023 Nov; 62(11):1352-1358. PubMed ID: 37753716
[TBL] [Abstract][Full Text] [Related]
12. Increased nerve growth factor- and tyrosine kinase A-like immunoreactivities in prurigo nodularis skin -- an exploration of the cause of neurohyperplasia.
Johansson O; Liang Y; Emtestam L
Arch Dermatol Res; 2002 Feb; 293(12):614-9. PubMed ID: 11875644
[TBL] [Abstract][Full Text] [Related]
13. Transcriptomic characterization of prurigo nodularis and the therapeutic response to nemolizumab.
Tsoi LC; Hacini-Rachinel F; Fogel P; Rousseau F; Xing X; Patrick MT; Billi AC; Berthier CC; Kahlenberg JM; Lazzari A; Wiegmann H; Ständer S; Piketty C; Julia V; Krishnaswamy JK; Gudjonsson JE
J Allergy Clin Immunol; 2022 Apr; 149(4):1329-1339. PubMed ID: 34857395
[TBL] [Abstract][Full Text] [Related]
14. Extracellular matrix and dermal nerve growth factor dysregulation in prurigo nodularis compared to atopic dermatitis.
Deng J; Parthasarathy V; Marani M; Bordeaux Z; Lee K; Trinh C; Cornman HL; Kambala A; Pritchard T; Chen S; Sutaria N; Oladipo OO; Kwatra MM; Alphonse MP; Kwatra SG
Front Med (Lausanne); 2022; 9():1022889. PubMed ID: 36619628
[TBL] [Abstract][Full Text] [Related]
15. Low density of sympathetic nerve fibers relative to substance P-positive nerve fibers in lesional skin of chronic pruritus and prurigo nodularis.
Haas S; Capellino S; Phan NQ; Böhm M; Luger TA; Straub RH; Ständer S
J Dermatol Sci; 2010 Jun; 58(3):193-7. PubMed ID: 20417061
[TBL] [Abstract][Full Text] [Related]
16. The Sleep Disturbance Numerical Rating Scale: Content Validity, Psychometric Validation, and Meaningful Within-Patient Change in Prurigo Nodularis.
Ständer S; Fofana F; Dias-Barbosa C; Rodriguez D; Budhiarso I; Jabbar-Lopez ZK; Piketty C; Vernon M; Puelles J
Dermatol Ther (Heidelb); 2023 Jul; 13(7):1587-1602. PubMed ID: 37329468
[TBL] [Abstract][Full Text] [Related]
17. Single-cell profiling of prurigo nodularis demonstrates immune-stromal crosstalk driving profibrotic responses and reversal with nemolizumab.
Ma F; Gharaee-Kermani M; Tsoi LC; Plazyo O; Chaskar P; Harms P; Patrick MT; Xing X; Hile G; Piketty C; Lazzari A; Van Delm W; Maverakis E; Nakamura M; Modlin RL; Kahlenberg JM; Billi AC; Julia V; Krishnaswamy JK; Gudjonsson JE
J Allergy Clin Immunol; 2024 Jan; 153(1):146-160. PubMed ID: 37506977
[TBL] [Abstract][Full Text] [Related]
18. Prurigo Nodularis Is Characterized by Systemic and Cutaneous T Helper 22 Immune Polarization.
Belzberg M; Alphonse MP; Brown I; Williams KA; Khanna R; Ho B; Wongvibulsin S; Pritchard T; Roh YS; Sutaria N; Choi J; Jedrych J; Johnston AD; Sarkar K; Vasavda C; Meixiong J; Dillen C; Bondesgaard K; Paolini JF; Chen W; Corcoran D; Devos N; Kwatra MM; Chien AL; Archer NK; Garza LA; Dong X; Kang S; Kwatra SG
J Invest Dermatol; 2021 Sep; 141(9):2208-2218.e14. PubMed ID: 33771530
[TBL] [Abstract][Full Text] [Related]
19. RNA sequencing reveals the transcriptome profile of the atopic prurigo nodularis with severe itching.
Shao Y; Zhu Y; Xiao Z; Shen Y; Dai B; Tang H; Wang D
Exp Dermatol; 2023 Jan; 32(1):30-40. PubMed ID: 36134503
[TBL] [Abstract][Full Text] [Related]
20. Prurigo nodularis: a review.
Lee MR; Shumack S
Australas J Dermatol; 2005 Nov; 46(4):211-18; quiz 219-20. PubMed ID: 16197418
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
